Source: Annual Congress 2002 - Pulmonary thromboembolism and pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Erkan, S. Findik, A. G. Atici, O. Uzun (Istanbul, Samsun, Turkey). Thrombolytic therapy in massive pulmonary thromboembolism. Eur Respir J 2002; 20: Suppl. 38, 1544

Member's Comments

No comment yet.

Related content which might interest you: Thrombolytic therapy in cases with massive pulmonary thromboembolism Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005 Effectiveness of thrombolytic therapy in pulmonary thromboembolism Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007 Complications of anticoagulant therapy in patients with pulmonary thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 604s Year: 2007 The treatment of sub massive pulmonary embolism: Thrombolytic or heparin? Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Fibrinolysis with tenecteplase in the management of massive pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 559s Year: 2004 Efficiency of r-TPA therapy in major venous thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 83s Year: 2007 Comparision of side effects between thrombolytic and anticoagulation therapy in patients with Pulmonary Embolism Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020 The changing of D-dimer in the thrombolytic process of pulmonary thromboembolism Source: Eur Respir J 2006; 28: Suppl. 50, 401s Year: 2006 Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach Source: Eur Respir J 2015; 45: 1142-1149 Year: 2015 Comparison of local and systemic thrombolytic treatment for acute massive pulmonary embolism Source: Eur Respir J 2007; 30: Suppl. 51, 544s Year: 2007 Effectiveness of anticoagulation with unfractionated heparin for acute pulmonary embolism Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 The outcome of anticoagulation alone therapy for patients with submassive pulmonary embolism Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 Therapeutic aspects of pulmonary embolism Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=25 Year: 2004 Comparision of catheter-directed therapy with the systemic thrombolysis for the treatment of acute pulmonary embolism with right ventricular dysfunction Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Successful use of thrombolytic therapy in the management of acute proximal pulmonary embolism without significant haemodynamic compromise Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005 Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension Year: 2019 Interventional treatment of pulmonary embolism: catheter-delivered local thrombolysis versus reduced-dose systemic thrombolysis Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management Year: 2021 Comparison of two regimens of oral anticoagulation in pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 632s Year: 2006 Efficacy of thrombolytic agents in the treatment of pulmonary embolism Source: Eur Respir J 2005; 26: 864-874 Year: 2005